Circulating Tumor DNA and the Future of Lymphoma Care

  Рет қаралды 380

Lymphoma Cancer Treatment NY - Weill Cornell

Lymphoma Cancer Treatment NY - Weill Cornell

Күн бұрын

The prospect that a simple blood test - a liquid biopsy - can reveal information about a patient’s cancer has led healthcare practitioners to feel both excitement and skepticism about the future. Dr. John Leonard discusses the potential value and limitations of using these blood tests to assess circulating tumor DNA (ctDNA) in people with lymphoma.

Пікірлер
REDLAMP 13: How Are Outcomes Improving for Patients with Transformed Follicular Lymphoma?
8:09
Lymphoma Cancer Treatment NY - Weill Cornell
Рет қаралды 1 М.
How to purify circulating cell-free DNA (cfDNA)
5:41
Thermo Fisher Scientific
Рет қаралды 32 М.
Brawl Stars Edit😈📕
00:15
Kan Andrey
Рет қаралды 59 МЛН
Hodgkin Lymphoma | Katie's Story
4:34
Lymphoma Cancer Treatment NY - Weill Cornell
Рет қаралды 53 М.
Weill Cornell Mantle Cell Lymphoma (MCL) Program
3:15
Lymphoma Cancer Treatment NY - Weill Cornell
Рет қаралды 444
ctDNA and MRD | 2023 Best of GI Cancer Conference
58:52
Total Health | Oncology
Рет қаралды 3,1 М.
Aspirin and cancer: the emerging evidence
54:01
Cardiff University School of Medicine
Рет қаралды 1,3 МЛН
The clinical use of ctDNA as a biomarker in TNBC
1:53
VJOncology
Рет қаралды 161
REDLAMP 14: Does Routine Imaging After DLBCL Remission Improve Post-Treatment Survival?
7:14
Lymphoma Cancer Treatment NY - Weill Cornell
Рет қаралды 291
Rian Harvey | Acute Myeloid Leukaemia (AML) | Spot Leukaemia
4:58
Leukaemia Care
Рет қаралды 2,7 М.